Suppr超能文献

选择性D2受体拮抗剂L-741,626对(+)-PD 128907在大鼠脑片中对中脑多巴胺神经元作用的拮抗作用。

Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.

作者信息

Bowery B J, Razzaque Z, Emms F, Patel S, Freedman S, Bristow L, Kulagowski J, Seabrook G R

机构信息

Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex.

出版信息

Br J Pharmacol. 1996 Dec;119(7):1491-7. doi: 10.1111/j.1476-5381.1996.tb16063.x.

Abstract
  1. The ability of PD 128907 to activate dopamine receptors in the ventral tegmental area, substantia nigra pars compacta, and striatum was investigated by use of in vitro electrophysiological recording and fast cyclic voltammetry. The affinity of a novel D2 selective antagonist L-741,626 for receptors activated by this agonist was measured to determine if its effects were mediated by D2 or D3 receptors. 2. The active (+) enantiomer of PD 128907 bound with high affinity and selectivity to rat D3 dopamine receptors. The Ki values for (+)-PD 128907 were 620 nM at D2, 1 nM at D3 and 720 nM at D4 receptors. 3. (+)-PD 128907 inhibited cell firing in both the ventral tegmental area and substantia nigra pars compacta with EC50 values of 33 nM (pEC50 = 7.48 +/- 0.10, n = 10) and 38 nM (pEC50 = 7.42 +/- 0.15, n = 5), respectively. No effects of (+)-PD 128907 (100 nM) were observed on glutamate or GABA-mediated synaptic potentials elicited by focal bipolar stimulation. 4. L-741,626 antagonized these effects of (+)-PD 128907 in a concentration-dependent and surmountable manner with an affinity, determined from Schild analysis, of 20 nM (pKB = 7.71 +/- 0.14) in the ventral tegmental area and 11 nM (pKB = 7.95 +/- 0.18) in the substantia nigra pars compacta. 5. (+)-PD 128907 also inhibited dopamine release in the caudate-putamen with an EC50 of 66 nM (n = 5). The affinity of L-741,626 for these nerve terminal autoreceptors (pKB = 7.71 +/- 0.06; = 20 nM) was identical to that observed on midbrain dopamine neurones. 6. These data demonstrate that the D3 receptor ligand (+)-PD 128907 is a potent agonist on rat midbrain dopamine neurones. However, its lack of regional selectivity, and the high affinity of the selective D2 receptor antagonist L-741,626 for receptors activated by (+)-PD 128907, was more consistent with an action on D2 autoreceptors rather than upon a D3 dopamine receptor subtype.
摘要
  1. 运用体外电生理记录和快速循环伏安法,研究了PD 128907激活腹侧被盖区、黑质致密部和纹状体中多巴胺受体的能力。测定了新型D2选择性拮抗剂L-741,626对该激动剂激活的受体的亲和力,以确定其作用是否由D2或D3受体介导。2. PD 128907的活性(+)对映体与大鼠D3多巴胺受体具有高亲和力和选择性结合。(+)-PD 128907在D2受体的Ki值为620 nM,在D3受体为1 nM,在D4受体为720 nM。3. (+)-PD 128907抑制腹侧被盖区和黑质致密部的细胞放电,EC50值分别为33 nM(pEC50 = 7.48 +/- 0.10,n = 10)和38 nM(pEC50 = 7.42 +/- 0.15,n = 5)。未观察到(+)-PD 128907(100 nM)对局部双极刺激引发的谷氨酸或GABA介导的突触电位有影响。4. L-741,626以浓度依赖性和可克服的方式拮抗(+)-PD 128907的这些作用,根据Schild分析确定,其在腹侧被盖区的亲和力为20 nM(pKB = 7.71 +/- 0.14),在黑质致密部为11 nM(pKB = 7.95 +/- 0.18)。5. (+)-PD 128907也抑制尾状核-壳核中的多巴胺释放,EC50为66 nM(n = 5)。L-741,626对这些神经末梢自身受体的亲和力(pKB = 7.71 +/- 0.06;= 20 nM)与在中脑多巴胺神经元上观察到的相同。6. 这些数据表明,D3受体配体(+)-PD 128907是大鼠中脑多巴胺神经元上的强效激动剂。然而,其缺乏区域选择性,以及选择性D2受体拮抗剂L-741,626对(+)-PD 128907激活的受体具有高亲和力这一事实,更符合其作用于D2自身受体而非D3多巴胺受体亚型。

相似文献

引用本文的文献

本文引用的文献

1
Some quantitative uses of drug antagonists.药物拮抗剂的一些定量应用。
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.
4
Functional relevance of dopamine receptors.多巴胺受体的功能相关性。
Trends Pharmacol Sci. 1995 Dec;16(12):406-8. doi: 10.1016/s0165-6147(00)89088-4.
8
Dopamine D2 and D3 receptors inhibit dopamine release.
J Pharmacol Exp Ther. 1994 Aug;270(2):475-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验